Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialNalinie Joharatnam‐Hogan, R. Steele, Stephen Falk et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 64
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD GroupKaitlyn K.H. Goey, Miriam Koopman, Halfdan Sørbye et al.|European Journal of Cancer|2018Cited by 34
FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testingSusan D. Richman, Richard Adams|Journal of Clinical Pathology|2022Cited by 10